NCT02551536View on ClinicalTrials.gov

Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
Allergic Rhinitis
Interventions
DRUG

Montelukast

DRUG

Fexofenadine

group B received FDC tablet of montelukast 10mg and fexofenadine 120 mg O.D

DRUG

Levocetrizine

group A recieved FDC tablet of montelukast 10 mg and levocetrizine 5mg O.D

All Listed Sponsors
lead

Indira Gandhi Medical College, Shimla

OTHER

NCT02551536 - Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis | Biotech Hunter | Biotech Hunter